65.47MMarket Cap13.12P/E (TTM)
9.2900High8.9301Low94.15KVolume9.2100Open9.1100Pre Close860.53KTurnover1.85%Turnover RatioLossP/E (Static)7.23MShares19.429952wk High0.88P/B46.12MFloat Cap8.250052wk Low--Dividend TTM5.10MShs Float710.1060Historical High--Div YieldTTM3.95%Amplitude8.2500Historical Low9.1400Avg Price1Lot Size
Precision BioSciences Stock Forum
Precision BioSciences Inc: Payment Includes $9.75 Mln Cash and $3.25 Mln in Imugene Limited Ordinary Shares Precision BioSciences Receives $13 Million in Proceeds From Imugene Convertible Note Maturity as Part of the August 2023 Azer-Cel Deal
Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis
Precision BioSciences Announces Common Stock Purchase By Members Of Management, Including CEO, For $300,000 In Private Placement
NEWS
PRECISION BIOSCIENCES ANNOUNCES COMMON STOCK PURCHASE BY MEMBERS OF MANAGEMENT FOR $300,000 IN A PRIVATE PLACEMENT
Precision BioSciences Announces Receipt of FDA Fast Track Designation for Ecur-506, Iecure’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (Otc) Deficiency
No comment yet